Lake Forest-based I-Flow Corp., maker of a targeted anesthesia device, has signed a pact with General Electric Co.’s GE Healthcare to look at using GE ultrasound gear to find the best placement of I-Flow’s products in patients.
Terms of the pact weren’t disclosed.
The two companies plan to hold clinical trials with an eye toward cross selling products to doctors. The companies plan to use ultrasound to identify the best spot for I-Flow’s device near nerves that detect pain.
I-Flow’s main product is On-Q, which delivers anesthesia to a targeted area in the days after surgery. The device is sold to hospitals and outpatient surgery centers, along with surgeons and anesthesiologists.
The company has yearly sales of about $100 million and a recent market value of $400 million.
